P3 Health Partners Price to Book Ratio 2020-2024 | PIII
Historical price to book ratio values for P3 Health Partners (PIII) over the last 10 years. The current price to book ratio for P3 Health Partners as of February 07, 2025 is 0.60.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| P3 Health Partners Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-07 | 0.20 | 0.58 | |
| 2024-09-30 | 0.39 | $0.34 | 1.15 |
| 2024-06-30 | 0.45 | $0.47 | 0.97 |
| 2024-03-31 | 1.03 | $0.46 | 2.22 |
| 2023-12-31 | 1.41 | $0.45 | 3.11 |
| 2023-09-30 | 1.47 | $0.60 | 2.45 |
| 2023-06-30 | 2.99 | $-0.44 | -6.86 |
| 2023-03-31 | 1.06 | $-0.01 | -96.36 |
| 2022-12-31 | 1.84 | $0.02 | 76.35 |
| 2022-09-30 | 4.62 | $0.32 | 14.38 |
| 2022-06-30 | 3.72 | $0.45 | 8.32 |
| 2022-03-31 | 7.82 | $1.10 | 7.10 |
| 2021-12-31 | 7.04 | $1.15 | 6.13 |
| 2021-09-30 | 9.86 | $-1.17 | -8.42 |
| 2021-06-30 | 9.89 | $0.47 | 21.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.073B | $1.266B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Enovis (ENOV) | United States | $2.544B | 16.95 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| Omnicell (OMCL) | United States | $1.826B | 39.83 |
| 10x Genomics (TXG) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |